Migraine Prevention Drugs Rarely Kept Up in German Claims Data Study
Most patients who later switched to a newer class of migraine preventive drug had not stayed on their earlier conventional preventive treatments for long, according to a retrospective cohort study based on German statutory health insurance claims data. Researchers analyzed prescription records for migraine patients who received a first prescription of an anti-calcitonin gene-related peptide…